Filing Flows › QHSLab (USAQ) › Q1 2025
QHSLab (USAQ) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 14, 2025
QHSLab (USAQ) reported revenue of $645K for the first quarter 2025 (Q1 2025), +32% from a year earlier and +3% from the quarter before. Operating margin was -1.9%, net loss $80K (12.3% of revenue).
QHSLab, Q1 2025: revenue $645K (+32% year over year), operating margin -1.9%, net loss $80K, operating cash flow −$50K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $645K | +3% | +32% |
| Operating profit | −$12K | -116% | — |
| Net earnings | −$80K | — | — |
| Operating cash flow | −$50K | -190% | — |
What changed
Revenue was $645K in Q1 2025, up 32% year over year and up 3% from the previous quarter. Allergy Diagnostic Kit Sales was the largest line at 41% of revenue. Integrated Service Program added $35K year over year (up 28%), 23% of the total change. Subscription Revenue declined 49%.
Gross margin was 66.6%, up 8.0 points from a year earlier. Operating costs exceeded revenue by $12K, an operating margin of -1.9%. Operating expenses grew 62% against revenue growth of 32%. The fastest-growing cost line was Research & development (+191%). The quarter ended with a net loss of $80K, narrower than the previous quarter's $288K loss. Net interest and other expense of $68K was the main reason.
Operating cash flow was −$50K. Non-cash charges added back $37K of depreciation and amortization. Working capital and other items used $7K.
Questions
What was QHSLab's revenue in the first quarter 2025?
QHSLab (USAQ) reported revenue of $645K for the first quarter 2025 (Q1 2025), +32% from a year earlier and +3% from the quarter before.
Was QHSLab profitable in the first quarter 2025?
Operating loss was $12K (-1.9% of revenue) and net loss $80K.
Source: QHSLab 10-Q on SEC EDGAR.